Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Glioblastoma 5Breast Neoplasms 3Brain Neoplasms 2Rectal Neoplasms 1Polycystic Ovary Syndrome 1Non-alcoholic Fatty Liver Disease 1Multiple Myeloma 1Intermittent Fasting 1Fatty Liver 1Estrogen Receptor-positive Breast Cancer 1Endometrial Neoplasms 1Drug Resistant Epilepsy 1Autism Spectrum Disorder 1Adenocarcinoma of Lung 1

Interventions

Letrozole 2palbociclib 1Fulvestrant 1Diet, Ketogenic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Estrogen Receptor-positive Breast Cancer × Diet, Ketogenic × 1 year × Clear all
NCT03962647 2026-04-30

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Completed
31 enrolled
Breast

Estrogen Receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡